Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Zai Lab

Explore full profile

Built on a vision that China would be the next destination for the pharmaceutical and healthcare industry

Pudong, ChinaFounded 2014Biotech & Life Sciences
Valuation $1.63B Market cap · 2026
Revenue $448M Latest reported FY
Total funding $500M–1B Disclosed equity funding

About Zai Lab

Zai Lab is a biopharmaceutical company focused on developing and commercializing innovative therapies for oncology, infectious diseases, and autoimmune disorders. The company serves patients with unmet medical needs, primarily in China and the Asia-Pacific region. Operating in the highly competitive biopharmaceutical market, Zai Lab collaborates with global partners to license and develop cutting-edge treatments. The business model revolves around research and development (R&D), clinical trials, and commercialization of novel drugs. Revenue is generated through product sales, licensing agreements, and strategic partnerships. Zai Lab's facilities in Suzhou, China, are designed to meet international standards, ensuring high-quality manufacturing of small molecule and biologic drugs.

Source: Dealroom company data

At a glance

Founded
2014
Headquarters
Pudong, China
Listing
IPO 2017
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Zai Lab.

See all news

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

Series B and later5 investors entered at this stage

Talent

Book a demo to see the people
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇨🇳 China75.3%
🇺🇸 United States18.7%
🇭🇰 Hong Kong3.9%
🇹🇼 Taiwan0.9%
🇸🇬 Singapore0.6%
Top 5 of 7 shown
Web traffic by country
20K monthly visits
across markets
🇺🇸 United States38%
🇨🇦 Canada19%
🇮🇳 India8%
🇬🇧 United Kingdom7.5%
🇭🇰 Hong Kong7%
Top 5 markets shown

Patents

Estimated portfolio value
$10M

9 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Zai Lab on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zai Lab on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles